Wnt-3A/β-catenin signaling induces transcription from the LEF-1 promoter

被引:216
作者
Filali, M
Cheng, NL
Abbott, D
Leontiev, V
Engelhardt, JF
机构
[1] Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA 52242 USA
[2] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA
关键词
D O I
10.1074/jbc.M107977200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Members of the Wnt family of secreted molecules have been established as key factors in determining cell fate and morphogenic signaling. It has long been recognized that Wnt induces morphogenic signaling through the Tcf/LEF-1 cascade by regulating free intracellular levels of beta-catenin, a co-factor for Tcf/LEF-1 transcription factors. In the present study, we have demonstrated that Wnt-3A can also directly induce transcription from the LEF-1 promoter. This induction was dependent on glycogen synthase kinase 3beta inactivation, a rise in free intracellular beta-catenin, and a short 110-bp Wnt-responsive element (W-RE) in the LEF-1 promoter. Linear and internal deletion of this WRE led to a dramatic increase in constitutive LEF-1 promoter activity and loss of Wnt-3A responsiveness. In isolation, the 110-bp WRE conferred context-independent Wnt-3A or beta-catenin(S37A) responsiveness to a heterologous SV40 promoter. Studies expressing dominant active and negative forms of LEF-1, beta-catenin, GSK-3beta, and beta-catenin/LEF-1 fusions suggest that Wnt-3A activates the LEF-1 promoter through a beta-catenin-dependent and LEF-1-independent process. Wnt-3A expression also induced multiple changes in the binding of factors to the WRE and suggests that regulatory mechanisms may involve modulation of a multiprotein complex. In summary, these results provide evidence for transcriptional regulation of the LEF-1 promoter by Wnt and enhance the mechanistic understanding of Wnt/beta-catenin signaling in the regulation of LEF-1-dependent developmental processes.
引用
收藏
页码:33398 / 33410
页数:13
相关论文
共 22 条
[1]   beta-catenin is a target for the ubiquitin-proteasome pathway [J].
Aberle, H ;
Bauer, A ;
Stappert, J ;
Kispert, A ;
Kemler, R .
EMBO JOURNAL, 1997, 16 (13) :3797-3804
[2]   Nuclear endpoint of Wnt signaling: Neoplastic transformation induced by transactivating lymphoid-enhancing factor 1 [J].
Aoki, M ;
Hecht, A ;
Kruse, U ;
Kemler, R ;
Vogt, PK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (01) :139-144
[3]   Wnt3a-/--like phenotype and limb deficiency in Lef1-/-Tcf1-/- mice [J].
Galceran, J ;
Fariñas, I ;
Depew, MJ ;
Clevers, H ;
Grosschedl, R .
GENES & DEVELOPMENT, 1999, 13 (06) :709-717
[4]   The human LEF-1 gene contains a promoter preferentially active in lymphocytes and encodes multiple isoforms derived from alternative splicing [J].
Hovanes, K ;
Li, TWH ;
Waterman, ML .
NUCLEIC ACIDS RESEARCH, 2000, 28 (09) :1994-2003
[5]   β-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer [J].
Hovanes, K ;
Li, TWH ;
Munguia, JE ;
Truong, T ;
Milovanovic, T ;
Marsh, JL ;
Holcombe, RF ;
Waterman, ML .
NATURE GENETICS, 2001, 28 (01) :53-57
[6]   Modulation of transcriptional regulation by LEF-1 in response to Wnt-1 signaling and association with β-catenin [J].
Hsu, SC ;
Galceran, J ;
Grosschedl, R .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (08) :4807-4818
[7]   Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3β and β-catenin and promotes GSK-3β-dependent phosphorylation of β-catenin [J].
Ikeda, S ;
Kishida, S ;
Yamamoto, H ;
Murai, H ;
Koyama, S ;
Kikuchi, A .
EMBO JOURNAL, 1998, 17 (05) :1371-1384
[8]   MOLECULAR-CLONING AND CHARACTERIZATION OF A HUMAN DNA-BINDING FACTOR THAT REPRESSES TRANSCRIPTION [J].
KAGEYAMA, R ;
PASTAN, I .
CELL, 1989, 59 (05) :815-825
[9]   Distinct WNT pathways regulating AER formation and dorsoventral polarity in the chick limb bud [J].
Kengaku, M ;
Capdevila, J ;
Rodriguez-Esteban, C ;
De La Peña, J ;
Johnson, RL ;
Belmonte, JCI ;
Tabin, CJ .
SCIENCE, 1998, 280 (5367) :1274-1277
[10]   Axin prevents Wnt-3a-induced accumulation of β-catenin [J].
Kishida, M ;
Koyama, S ;
Kishida, S ;
Matsubara, K ;
Nakashima, S ;
Higano, K ;
Takada, R ;
Takada, S ;
Kikuchi, A .
ONCOGENE, 1999, 18 (04) :979-985